Researchers found that the degree to which a person with idiopathic Parkinson disease engages in these avoidance tactics—such as putting a hand in the pocket to hide a tremor—is moderately predictive of social anxiety. The trouble is, such strategies may make anxiety worse, and patients can develop social anxiety disorder.
Responses from the Fox Insight study describe how patients with Parkinson disease experience OFF periods as expressed in both motor and nonmotor symptoms.
The authors said long-term trends in Parkinson disease were previously unknown and that the findings are important to determining national health care priorities.
Researchers hope that the benefits seen in a new protocol for deep brain stimulation (DBS) in Parkinsonian mice will extend to humans.
More than 1 in 3 patients with Parkinson disease were found to experience minor hallucinations, which were linked with worse quality of life and poor sleep outcomes.
Mild cognitive impairment (MCI) affects older adults both with and without Parkinson disease (PD) and can impair the ability to participate in activities of daily living (IADL); a recent study sought to determine how both groups performed, compared with healthy adults, according to 4 measurements.
Current knowledge about how Parkinson disease (PD) affects patients from different socioeconomic or ethnic groups is lacking, said The Michael J. Fox Foundation for Parkinson’s Research (MJFF), and diverse groups are underrepresented in research.
This follow-up study of patients first analyzed 10 years ago sought to determine if health-related quality of life (HRQOL) was still a reliable predictor of Parkinson disease severity, especially at it relates to Hoehn-Yahr stage increase.
In interviews with patients with Parkinson disease and their care partners, study authors noted that OFF periods can impair socialization, physical function, leisure activities, driving, and other means of independence.
Neuropalliative care is an emerging field for those with conditions such as Parkinson disease, multiple system atrophy, progressive supranuclear palsy, corticobasal syndrome, and other diseases, but access to care remains limited, according to a recent survey.
Results of the SAFINONMOTOR open-label study found that safinamide was safe and effective in improving pain of patients with Parkinson disease at 6 months.
Patients with idiopathic Parkinson disease given Origanum majorana tea in combination with conventional medication exhibited significant improvements in depressive and nonmotor symptom burden vs placebo, although improvement of motor symptoms was not significant.
An overview of the latest news in Parkinson disease reported across clinical research.
Postoperative management of deep brain stimulation in patients with Parkinson disease was shown to be safe and effective when administered at home, which may reduce necessity of in-clinic visits and care access issues.
An overview of the latest news in Parkinson disease (PD) reported across MJH Life Sciences™.
Pimavanserin (Nuplazid) initiation among patients with Parkinson disease was associated with greater risk of 30-day hospitalization and mortality up to one year compared with non-users.
An overview of the latest news in Parkinson disease reported across MJH Life Sciences™.
Findings of the Adult Changes in Thought study present a significant link between long-term air pollution exposure and increased risk of dementia.
An overview of the latest news in Parkinson disease reported across MJH Life Sciences™.
A significant risk of neurodegenerative disease was found in an analysis of male former professional soccer players, with defensive outfield players and those with careers longer than 15 years particularly at risk.
An overview of the latest news in Parkinson disease reported across MJH Life Sciences™.
People with prior incidence of traumatic brain injury and exposure to lead were shown to be at elevated risk of Parkinson disease development, with family history also found to influence risk.
Patients with Parkinson disease treated with acupuncture-related therapies combined with conventional medication exhibited significant improvements in motor function and experiences of daily living, although the quality of findings may warrant future research.
An overview of the latest news in Parkinson disease reported across MJH Life Sciences™.
